Lymphocyte-predominant Hodgkin lymphoma: Patient outcomes from a large single-institution series with long follow-up

被引:0
|
作者
Chen, R. C. [1 ]
Chin, M. S. [2 ]
Ng, A. K. [3 ]
Silver, B. [3 ]
Mauch, P. M. [3 ]
机构
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1016/j.ijrobp.2008.06.421
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S123 / S124
页数:2
相关论文
共 50 条
  • [21] Single-Institution Follow-Up Experience with Telemedicine
    Leong, Joon Yau
    Syed, Ali
    Uhr, Alexander
    Chandrasekar, Thenappan
    Gomella, Leonard
    Glassman, Deborah
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S322 - S323
  • [22] RITUXIMAB-BASED RISK-ADAPTED TREATMENT STRATEGY IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA: 7-YEARS FOLLOW-UP
    Pugliese, N.
    Picardi, M.
    Della Pepa, R.
    Giordano, C.
    Muriano, F.
    Leone, A.
    Delle Cave, G.
    D'Ambrosio, A.
    Marafioti, V.
    Pane, F.
    HAEMATOLOGICA, 2020, 105 : S102 - S102
  • [23] Characteristics and Outcomes of Patients With Lymphocyte-Predominant Hodgkin Lymphoma Versus Classical Hodgkin Lymphoma: A Population-Based Analysis
    Gerber, N.
    Atoria, C. L.
    Elkin, E. B.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S153 - S154
  • [24] LONG TERM FOLLOW-UP OF ADVANCED HODGKIN LYMPHOMA TREATED WITH BEACOPP REGIMEN - A SINGLE INSTITUTION EXPERIENCE
    Mihaljevic, B.
    Antic, D.
    Jakovic, L. R.
    Andjelic, B.
    Tomin, D.
    Petrovic, M.
    HAEMATOLOGICA, 2010, 95 : S22 - S23
  • [25] Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma (vol 5, pg 368, 2008)
    Suh, Grace
    Younes, Anas
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (08): : 493 - 493
  • [26] Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated with Radiotherapy
    Solanki, Abhishek A.
    LeMieux, Melissa Horoschak
    Chiu, Brian C. -H.
    Mahmood, Usama
    Hasan, Yasmin
    Koshy, Matthew
    PLOS ONE, 2013, 8 (09):
  • [27] Nodular Lymphocyte Predominant Hodgkin Lymphoma. Experience in a Single Institution in Argentina
    Alfaro, Elizabeth M.
    La Rosa, Cristian G. Sanchez
    Guitter, Myriam
    Millan, Natalia
    Montanari, Andrea
    Galluzzo, Laura
    Felice, Maria Sara
    Zubizarreta, Pedro
    BLOOD, 2016, 128 (22)
  • [28] Advanced-stage, chemorefractory lymphocyte-predominant Hodgkin's disease: Long-term follow-up of allografting and monoclonal antibody therapy
    Lush, RJ
    Jones, SG
    Haynes, AP
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) : 734 - 735
  • [29] Lymphocyte-predominant Hodgkin lymphoma-clinical features and treatment outcomes from a 30-year experience
    Jackson, C.
    Sirohi, B.
    Cunningham, D.
    Horwich, A.
    Thomas, K.
    Wotherspoon, A.
    ANNALS OF ONCOLOGY, 2010, 21 (10) : 2061 - 2068
  • [30] Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a challenging case of histologic transformation to large B cell lymphoma
    Meseure, D.
    Copie, C.
    Boudjemaa, S.
    Chetaille, B.
    Curtillet, C.
    Gaulard, P.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 192 - 192